This post contains affiliate links, which means the website may earn a small commission at no extra cost to you if you make a purchase through them. The HerHealth101 team only recommends products that align with our mission to support women’s health, and is not a reflection of any specific author. Your support helps keep this site growing. Thank you!
Thinking about starting a family when you are already managing thyroid disease can stir up plenty of extra questions, and honestly, a fair amount of worry. You are likely already familiar with tracking your labs and adjusting your medications, yet adding pregnancy into the mix brings a whole new set of variables to navigate. Fortunately, the American Thyroid Association recently updated its clinical guidelines for managing thyroid dysfunction across preconception, pregnancy, and the postpartum window, replacing the older 2017 standards. A multidisciplinary team spent years reviewing the latest evidence to give us clearer direction, and the big picture is deeply encouraging.
Before diving into the specifics, remember that clinical guidelines are meant to serve as a roadmap rather than rigid rules. Every body responds differently, so your best outcomes will always come from partnering closely with your care team to tailor these recommendations to your exact health picture. For anyone who is pregnant or actively trying, the updated guidance also advises doctors to weigh risks carefully before ordering high iodine medications or imaging tests with iodinated contrast. You will also want to keep daily dietary iodine supplements under 500 mcg, as excessive iodine can disrupt both maternal and fetal thyroid function.

Preparing for Pregnancy with Hypothyroidism
If you manage an underactive thyroid, the newest evidence offers wonderful reassurance. When levothyroxine treatment keeps your thyroid levels balanced in a normal range, your chances of conceiving are optimized, and your fertility and pregnancy outcomes mirror those of women without thyroid conditions.
Because your baby relies entirely on your thyroid hormones during early development, staying ahead of your numbers is essential:
- Preconception lab targets: Checking your thyroid function every three to six months while trying to conceive is a smart baseline, aiming for a TSH between 0.5 and 2.5 mU/L. This slightly tighter upper limit protects you from slipping into undertreatment during fertility treatments or those crucial early weeks.
- Adjusting your medication: Once you see a positive test, your body will demand more hormone quickly. Most women need roughly a 25 percent increase in their levothyroxine dose by week 12, which your doctor might manage by bumping up your daily dose. By week 20, requirements typically reach about 50 percent above your starting dose.
- Ongoing lab monitoring: Expect to have your thyroid function checked every four weeks through mid pregnancy, followed by at least one more check around the 30 week mark.
- Medication choices: Liothyronine (Cytomel) and desiccated thyroid extracts are not recommended when planning a pregnancy or expecting. Your baby’s developing nervous system depends heavily on converting maternal T4 into active T3, and combination therapies tend to leave lower circulating levels of T4 available for that vital conversion.

Navigating Graves’ Disease and Treatment Choices
Managing an overactive thyroid takes extra vigilance during pregnancy because uncontrolled hyperthyroidism carries serious risks, including pregnancy loss, high blood pressure, restricted fetal growth, stillbirth, and seizure disorders in babies, alongside severe complications like thyroid storm or heart failure for mothers. Before trying to conceive, doctors recommend waiting until your thyroid levels are both normal and steady, confirmed by at least two normal lab panels drawn at least six weeks apart. Once your levels are stable, your fertility outlook looks very similar to women without a history of Graves’ disease.
Depending on your current treatment path, your care plan will shift in specific ways:
- Antithyroid drugs: Both methimazole and propylthiouracil (PTU) carry a small risk of birth defects, though PTU is considered the safer choice during the first trimester. Because of this, experts recommend switching from methimazole to PTU while trying to conceive, leaving the decision of whether to switch back after the first trimester up to you and your doctor. Interestingly, pregnancy naturally boosts immune tolerance, meaning antibody levels often drop. If you have been stable on a low dose of medication for at least six months prior to conceiving, you might even be a candidate to reduce or pause your medication during pregnancy under close supervision.
- Radioactive iodine: Because radioactive iodine crosses the placenta and can harm the baby’s thyroid gland, it is strictly off limits during pregnancy, and you will need to wait six months after treatment before trying to conceive. Notably, the updated guidance warns that Graves’ antibodies (TSI or TRAb) can remain elevated for one to three years after radioactive iodine therapy, longer than the 2017 guidelines previously suggested, which raises the risk of fetal or newborn hyperthyroidism.
- Thyroid surgery: While general anesthesia is now recognized as safe during any trimester if urgent surgery is unavoidable, doctors still strongly prefer scheduling a thyroidectomy during the second trimester when possible, ideally with an experienced, high volume surgeon.

Monitoring Mother and Baby Throughout Gestation
Even if your thyroid levels are currently normal or you have already had definitive treatment like surgery or radioactive iodine, Graves’ antibodies can still cross the placenta and stimulate your baby’s thyroid. Every pregnant patient with a history of Graves’ disease should have their TSH, Free T4, and antibody levels (TRAb or TSI) checked in the first trimester. If those antibodies measure more than three times the upper limit of normal, you will need repeat antibody testing at 18 to 20 weeks, followed by monthly fetal ultrasounds if levels stay elevated.
Your ongoing monitoring schedule depends on where you stand with treatment:
- Active antithyroid medication: You will need bloodwork every two to four weeks to keep your Free T4 at or slightly above the upper third of the normal range, paired with monthly fetal ultrasounds starting around 18 to 20 weeks to watch for a fetal goiter.
- Paused medication: If you were able to stop your pills during pregnancy but started with high first trimester antibodies, your team will recheck antibodies at 18 to 22 weeks and again at 30 to 34 weeks alongside fetal monitoring, tapering off extra scans if your levels drop safely below that three times threshold.
- Clinical remission: If you have maintained normal levels without medication for at least a year, simple lab checks once per trimester are usually sufficient.
- Post surgery or radioactive iodine: Even when you take levothyroxine for hypothyroidism after definitive treatment, lingering high antibodies can overstimulate your baby’s thyroid. In rare cases, doctors may temporarily add antithyroid medication alongside your levothyroxine so both you and your baby stay balanced.

What to Expect in the Postpartum Period
Once your baby arrives, your immune system and hormone demands shift rapidly again, making those first few months just as important as pregnancy itself.
- Returning to baseline doses: If you increased your levothyroxine for hypothyroidism during pregnancy, you can typically drop right back down to your pre pregnancy dose after delivery, followed by a lab check six weeks later.
- Breastfeeding safety: Antithyroid medications do pass into breast milk in small amounts, but daily doses under 20 mg for methimazole or under 750 mg for PTU are considered safe and are not expected to impact your baby’s thyroid function.
- Watching for postpartum flares: Because immune tolerance fades after childbirth, Graves’ antibodies frequently rebound. Women who were in remission face a 25 to 55 percent chance of relapse, so plan on getting your thyroid labs checked at four to six weeks and again at four to six months postpartum, or sooner if familiar symptoms creep back.
- Newborn checkups: If your antibody levels were elevated during pregnancy, pediatricians will keep a close eye on your newborn for signs of temporary hyperthyroidism. While any antithyroid medication that crossed the placenta clears a baby’s system within days, maternal antibodies linger longer, occasionally requiring a short course of treatment for your little one until those antibodies naturally clear.
Walking into family planning with clear, current science on your side allows you to ask sharper questions and feel grounded in your care. Schedule a preconception visit with your endocrinologist or OBGYN to review your baseline labs, confirm your medication plan, and build a monitoring timeline that supports both you and your future baby every step of the way.
Full publication: https://journals.sagepub.com/doi/full/10.1177/10507256261445624
